Stephens Inc Lantheus Holdings, Inc. Transaction History

Stephens Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$61.42 - $86.29 $598,660 - $841,068	9,747 New	9,747 $686,000
Q3 2019 Oct 18, 2019	SELL	$21.01 - $28.94 $249,829 - $344,125	-11,891 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$23.33 - $28.3 $57,391 - $69,618	-2,460 Reduced 17.14%	11,891 $337,000
Q1 2019 May 03, 2019	SELL	$14.93 - $25.1 $67,438 - $113,376	-4,517 Reduced 23.94%	14,351 $351,000
Q4 2018 Feb 11, 2019	BUY	$12.68 - $19.01 $61,789 - $92,635	4,873 Added 34.82%	18,868 $295,000
Q3 2018 Nov 14, 2018	BUY	$13.1 - $16.35 $183,334 - $228,818	13,995 New	13,995 $209,000

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.8B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.